News
July 10, 2020
NLA Releases Official Scientific Statement on Genetic Testing in Dyslipidemia
The NLA today announced the release of its official scientific statement on the use of genetic testing in dyslipidemia.
Read More...July 2, 2020
NLA's New Plan for Education in September
As we’ve monitored the trajectory of COVID-19 cases and local restrictions...
Read More...June 9, 2020
The NLA Welcomes New Leadership
JACKSONVILLE, Fla. — Joseph J. Saseen, PharmD, CLS, FNLA, officially assumed the role of National Lipid Association (...
Read More...June 9, 2020
NEXLIZET™ (Bempedoic Acid and Ezetimibe) Now Available in U.S. Pharmacies
Esperion has announced that NEXLIZET™ (bempedoic acid and ezetimibe) Is now available in pharmacies in the United...
Read More...June 2, 2020
NLA's Commitment to Diversity, Inclusion, and Equality
The mission of the National Lipid Association is to enhance lipid...
Read More...